Resultados de procura - Lønning, P E
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer... por Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P. O., Lønning, P. E.
Publicado 1996Text -
11
-
12
-
13
-
14
-
15
-
16
-
17
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors por Flågeng, M Hauglid, Haugan Moi, L L, Dixon, J M, Geisler, J, Lien, E A, Miller, W R, Lønning, P E, Mellgren, G
Publicado 2009Text -
18
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signalling por Chekenya, M, Krakstad, C, Svendsen, A, Netland, IA, Staalesen, V, Tysnes, B.B, Selheim, F, Wang, J, Sakariassen, P.Ø, Sandal, T, Lønning, P.E, Flatmark, T, Enger, P.Ø, Bjerkvig, R, Sioud, M, Stallcup, WB
Publicado 2008Text -
19
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES por Cheang, M. C. U., Bliss, J. M., Viale, G., Speirs, V., Palmieri, C., Shaaban, A., Lønning, P. E., Morden, J., Porta, N., Jassem, J., van De Velde, C. J., Rasmussen, B. B., Verhoeven, D., Bartlett, J. M. S., Coombes, R. C.
Publicado 2017Text